| The relationship between antimicrobial use and antimicrobial resistance in Europe SLAM Bronzwaer, O Cars, U Buchholz, S Mölstad, W Goettsch, ... Emerging infectious diseases 8 (3), 278, 2002 | 1034 | 2002 |
| Good practices for real‐world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in … ML Berger, H Sox, RJ Willke, DL Brixner, HG Eichler, W Goettsch, ... Value in Health 20 (8), 1003-1008, 2017 | 607 | 2017 |
| Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study WG Goettsch, SD Bos, N Breekveldt-Postma, M Casparie, RMC Herings, ... European journal of cancer 41 (18), 2868-2872, 2005 | 455 | 2005 |
| Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands W Goettsch, W Van Pelt, N Nagelkerke, MGR Hendrix, AGM Buiting, ... Journal of antimicrobial chemotherapy 46 (2), 223-228, 2000 | 376 | 2000 |
| What is real-world data? A review of definitions based on literature and stakeholder interviews A Makady, A de Boer, H Hillege, O Klungel, W Goettsch Value in health 20 (7), 858-865, 2017 | 373 | 2017 |
| From adaptive licensing to adaptive pathways: delivering a flexible life‐span approach to bring new drugs to patients HG Eichler, LG Baird, R Barker, B Bloechl‐Daum, F Børlum‐Kristensen, ... Clinical Pharmacology & Therapeutics 97 (3), 234-246, 2015 | 258 | 2015 |
| Graphical depiction of longitudinal study designs in health care databases S Schneeweiss, JA Rassen, JS Brown, KJ Rothman, L Happe, P Arlett, ... Annals of internal medicine 170 (6), 398-406, 2019 | 236 | 2019 |
| Policies for use of real-world data in health technology assessment (HTA): a comparative study of six HTA agencies A Makady, R Ten Ham, A de Boer, H Hillege, O Klungel, W Goettsch Value in Health 20 (4), 520-532, 2017 | 205 | 2017 |
| Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study FJA Penning-van Beest, F Termorshuizen, WG Goettsch, OH Klungel, ... European heart journal 28 (2), 154-159, 2007 | 198 | 2007 |
| Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis FJA Penning-van Beest, WG Goettsch, JA Erkens, RMC Herings Clinical therapeutics 28 (2), 236-242, 2006 | 179 | 2006 |
| Improving transparency to build trust in real-world secondary data studies for hypothesis testing—why, what, and how: recommendations and a road map from the real-world … LS Orsini, M Berger, W Crown, G Daniel, HG Eichler, W Goettsch, J Graff, ... Value in Health 23 (9), 1128-1136, 2020 | 144 | 2020 |
| The HTA Core Model®—10 years of developing an international framework to share multidimensional value assessment FB Kristensen, K Lampe, C Wild, M Cerbo, W Goettsch, L Becla Value in Health 20 (2), 244-250, 2017 | 139 | 2017 |
| Inappropriate initial treatment of secondary intra‐abdominal infections leads to increased risk of clinical failure and costs MCJM Sturkenboom, WG Goettsch, G Picelli, B In ‘t Veld, DD Yin, ... British journal of clinical pharmacology 60 (4), 438-443, 2005 | 127 | 2005 |
| Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands WG Goettsch, JN Bouwes Bavinck, RMC Herings Journal of the European Academy of Dermatology and Venereology 20 (7), 834-839, 2006 | 124 | 2006 |
| The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study MJM Panneman, WG Goettsch, P Kramarz, RMC Herings Drugs & aging 20, 833-839, 2003 | 115 | 2003 |
| Unmet medical need: an introduction to definitions and stakeholder perceptions RA Vreman, I Heikkinen, A Schuurman, C Sapede, JL Garcia, N Hedberg, ... Value in health 22 (11), 1275-1282, 2019 | 110 | 2019 |
| Using real-world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies A Makady, A van Veelen, P Jonsson, O Moseley, A D’Andon, A de Boer, ... Pharmacoeconomics 36, 359-368, 2018 | 106 | 2018 |
| Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions S Kleijnen, E George, S Goulden, A d'Andon, P Vitré, B Osińska, ... Value in health 15 (6), 954-960, 2012 | 103 | 2012 |
| Long term persistence with statin treatment in daily medical practice AK Mantel-Teeuwisse, WG Goettsch, OH Klungel, A De Boer, ... Heart 90 (9), 1065-1066, 2004 | 97 | 2004 |
| CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research D Kotecha, FW Asselbergs, S Achenbach, SD Anker, D Atar, C Baigent, ... The Lancet Digital Health 4 (10), e757-e764, 2022 | 96 | 2022 |